Janux Therapeutics, Inc. (JANX) has a market capitalization of $927.07M and trades at $15.24. The 52-week range is 12.12-35.34.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.3, Earnings Per Share (EPS) of $-1.83, annual revenue of $10M.
The stock has a beta of 2.81, operates in the Healthcare sector.
